Maria Bjurberg
21 – 30 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)
(
- Contribution to journal › Article
- 2015
-
Mark
Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
(
- Contribution to journal › Article
-
Mark
An anesthetic method compatible with (18)F-FDG-PET studies in mice.
(
- Contribution to journal › Article
-
Mark
Cervixcancer en klinisk utmaning
(
- Contribution to journal › Article
- 2013
-
Mark
Clinical Impact of 2-Deoxy-2-[18F]fluoro-D-Glucose (FDG)-Positron Emission Tomography (PET) on Treatment Choice in Recurrent Cancer of the Cervix Uteri.
(
- Contribution to journal › Article
- 2010
-
Mark
FDG-PET in Cervical Cancer - Translational Studies
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Early Metabolic Flare in Squamous Cell Carcinoma after Chemotherapy is a Marker of Treatment Sensitivity In Vitro
(
- Contribution to journal › Article
- 2009
-
Mark
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.
(
- Contribution to journal › Article
-
Mark
Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.
(
- Contribution to journal › Article
- 2008
-
Mark
Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase.
(
- Contribution to journal › Article